Acute urinary retention following self treatment of genital warts with imiquimod 5% cream [6]

Sexually Transmitted Infections

Volumn 80, Issue 5, 2004, Pages 419-420

  McQuillan, Orla ^a   Higgins, S P ^a  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; PODOPHYLLOTOXIN; VALACICLOVIR; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

ADOLESCENT; ANAMNESIS; BLADDER CATHETERIZATION; CASE REPORT; CONDYLOMA; CREAM; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG UTILIZATION; DRUG WITHDRAWAL; DYSURIA; EDEMA; ERYTHEMA; FEMALE; GENITAL ULCER; HUMAN; LETTER; OUTCOMES RESEARCH; PATIENT EDUCATION; PHIMOSIS; PHYSICAL EXAMINATION; PRESCRIPTION; PRIORITY JOURNAL; URINE RETENTION; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; CONDYLOMA ACUMINATUM; DRUG SELF ADMINISTRATION;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; AMINOQUINOLINES; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; SELF ADMINISTRATION; URINARY RETENTION;

EID: 6044261573     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2004.009811     Document Type: Letter

References (2)

1. 3M Pharmaceuticals. Data on file (Integrated Summary of Safety).
2. Gilson R, et al. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. AIDS 1999;13:2397-404.